Viz HCM
Overview
Viz HCM is an AI-powered, mobile-based algorithm developed by Viz.ai, designed to advance disease detection and cardiac care coordination. It specializes in detecting suspected Hypertrophic Cardiomyopathy (HCM) from standard 12-lead electrocardiograms (ECGs) in real-time. Upon detection, Viz HCM automatically notifies the appropriate care specialists, facilitating timely follow-up and diagnosis. This solution helps healthcare providers identify patients who might otherwise go undiagnosed for years, significantly reducing the time to diagnosis and accelerating access to life-saving treatments. Viz HCM is part of the broader Viz.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection
- Real-time disease detection from electrocardiograms
- Mobile-based alerts and notifications to multidisciplinary care teams
- Automated direction of patients to appropriate care specialists
- Reduces time to diagnosis and treatment for HCM
- Streamlines cardiac care coordination and clinical workflows
- Seamless integration with existing clinical workflows, EHR, and PACS systems
- Clinically validated with extensive real-world evidence and publications
- Secure and compliant environment adhering to HIPAA, SOC 2 Type II, and GDPR standards
Use Cases
- Early detection of Hypertrophic Cardiomyopathy (HCM) in general patient populations
- Rapid triaging of patients with suspected HCM to specialized care
- Improving patient follow-up and engagement for cardiac conditions
- Accelerating diagnosis and treatment decisions in cardiology departments
- Optimizing resource utilization and efficiency within hospitals and health systems
- Enhancing communication and collaboration among multidisciplinary cardiac care teams
What Physicians Need to Know
Viz.ai One offers an AI-powered care coordination solution that integrates analysis of EKGs, echocardiograms, and CT scans to accelerate diagnosis and streamline workflows for cardiovascular conditions like Hypertrophic Cardiomyopathy, Cardiac Amyloidosis, and Acute Coronary Syndrome. The real-time communication features can help activate care teams quickly.
The Viz.ai platform is designed for easy integration and is equipped with dedicated 24/7 on-call clinical specialists, implementation experts, and a customer success team for support.
Details
| Category | Cardiology AI, Clinical Decision Support & Reference |
| Pricing | Unknown |
| Mobile App | 1 |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Emergency Medicine, Hospital Medicine |
Support & Reliability
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2023-08-03 | DEN230003 De Novo | Viz HCM |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Viz HCM
Videos
Product demos, reviews, and walkthroughs for Viz HCM.
Viz.ai at ACC 2025: Using Viz.ai for Earlier HCM Detection
Viz. ai
Viz HCM: Using AI to advance diagnosis and management of hypertrophic cardiomyopathy
Viz. ai
Patient case of HCM flagged by Viz HCM
Viz. ai
HCM Education Series: Diagnostic Approaches in HCM
Viz. ai
Robust Development of Viz HCM algorithm
Viz. ai
5 years to an HCM diagnosis should not be the norm
Viz. ai
Frequently Asked Questions
Compare Viz HCM
VS
VS
VS
VS
Investors who backed Viz HCM
Funded through the company that built this tool.










